Implications of Clinical Trial Design on Sample Size Requirements
Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4
Abstract
The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison groups reduce the risk of bias. The design must also provide sufficient statistical power to detect a clinically meaningful treatment effect and maintain a nominal level of type I error. An attempt to integrate neurocognitive science into an RCT poses additional challenges. Two particularly relevant aspects of such a design often receive insufficient attention in an RCT. Multiple outcomes inflate type I error, and an unreliable assessment process introduces bias and reduces statistical power. Here we describe how both unreliability and multiple outcomes can increase the study costs and duration and reduce the feasibility of the study. The objective of this article is to consider strategies that overcome the problems of unreliability and multiplicity.
Authors and Affiliations
Andrew C. Leon
Using Event Related Potentials to Explore Stages of Facial Affect Recognition Deficits in Schizophrenia
Schizophrenia patients show impairments in identifying facial affect; however, it is not known at what stage facial affect processing is impaired. We evaluated 3 event-related potentials (ERPs) to explore stages of facia...
Making Progress in Schizophrenia Research
Current Psychopathological Issues in Psychosis: Towards a Phenome-wide Scanning Approach
Supported in part by a grant of the Health Department of the Navarre Government, Spain (55/2007).
Pharmacological Interventions for Clozapine-induced Hypersalivation
Clozapine is widely used for people with schizophrenia. Agranulocytosis, weight gain, and cardiac problems are serious problems associated with clozapine use. Hypersalivation, sometimes of a gross and socially unacceptab...
Psychosis Endophenotypes in Schizophrenia and Bipolar Disorder
Recent studies provide considerable evidence that schizophrenia and bipolar disorder may share overlapping etiologic determinants. Identifying disease-related genetic effects is a major focus in schizophrenia and bipolar...